The treatment landscape is beginning to shift, however, with the recent approvals of the new TB drugs bedaquiline and delamanid.

p53 (phospho S37)

ZEN-3694 : Epigenetic Tools (The Writers, The Readers and The Erasers) and Their Implications in Cancer Therapy